CoreAge Rx vs MyFastRx
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and MyFastRx head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 79 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make MyFastRx a bad call — it's best for cash-pay patients comparing a short initial purchase with a longer prepaid commitment. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | MyFastRx |
|---|---|---|
| Brief Score | 94/100 (A) | 79/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | $139/mo ongoing New customers: $69 first month with MY70; annual option $948 upfront. Full price details$139/mo ongoing; $69 first month for new customers with MY70; $948 prepaid for 12 months ($79/mo equivalent) |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | $199/mo ongoing New customers: $129 first month with MY70; annual option $1,488 upfront. Full price details$199/mo ongoing; $129 first month for new customers with MY70; $1,488 prepaid for 12 months ($124/mo equivalent) |
| Coverage | US only; restrictions by state, confirmed at intake | Availability depends on state, treatment and clinical eligibility |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
MyFastRx: Standard ongoing prices are $139/month for semaglutide and $199/month for tirzepatide. Introductory discounts and annual prepaid equivalents are separate offers.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.